NASDAQ : IXHL
Incannex Healthcare Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · Australia
Last price 2.58 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 32.37M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 31.61M |
| Enterprise Value | -36.00M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 12.54M |
| Shares Outstanding | 12.54M |
| Shares Change (YoY) | +915.12% |
| Shares Change (QoQ) | -0.56% |
| Owned by Insiders (%) | 11.52% |
| Owned by Institutions (%) | 5.27% |
| Float | 10.18M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.47 |
| P/TBV Ratio | 0.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 48.81 |
| Quick Ratio | 48.61 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -47.80% |
| Return on Assets (ROA) | -24.58% |
| Return on Invested Capital (ROIC) | -28.31% |
| Return on Capital Employed (ROCE) | -25.70% |
| Weighted Average Cost of Capital (WACC) | 19.68% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.61M |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.82 |
| 52-Week Price Change | -75.48% |
| 50-Day Moving Average | 3.18 |
| 200-Day Moving Average | 4.20 |
| Relative Strength Index (RSI) | 28.87 |
| Average Volume (20 Days) | 63,074 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 411,587 |
| Short Previous Month | 456,097 |
| Short % of Shares Out | 3.28% |
| Short % of Float | 4.04% |
| Short Ratio (days to cover) | 4.45 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -18.37M |
| Pretax Income | -19.30M |
| Net Income | -19.30M |
| EBITDA | -18.13M |
| EBIT | -18.37M |
| Earnings Per Share (EPS) | -$1.66 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 67.71M |
| Total Debt | 96,000 |
| Net Cash | 67.62M |
| Net Cash Per Share | $5.39 |
| Equity (Book Value) | 67.37M |
| Book Value Per Share | 5.37 |
| Working Capital | 71.34M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -12.87M |
| Capital Expenditures | -10,000 |
| Depreciation & Amortization | 240,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -12.88M |
| FCF Per Share | -$1.03 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -915.12% |
| Shareholder Yield | -915.12% |
| Earnings Yield | -65.70% |
| FCF Yield | -40.73% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Feb 27, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |